InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Levin Mark J, 董事. Director active across 1 company, notably Fulcrum Therapeutics, Inc.. In total, 2 disclosures have been published. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Mark J. Levin is a Board Member at Fulcrum Therapeutics, Inc. He participates in the governance of the company and strategic decision-making. Mark brings expertise in biotechnology, contributing to innovation and growth at Fulcrum.